Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nourishing Yin toning granule (养阴通脑颗粒) is a Traditional Chinese Medicine (TCM) formula in granule form. It is currently undergoing investigation in a Phase 3 clinical trial for the treatment of ischemic stroke, specifically targeting patients presenting with qi deficiency and blood stasis. Rooted in TCM principles, its therapeutic approach involves "nourishing Yin" to restore bodily fluids, mitigate internal heat, and promote overall restoration, while "toning brain" aims to enhance cerebral function and circulation. As a multi-component herbal preparation, its effects are believed to be mediated through the synergistic action of various active small molecules on multiple biological targets and pathways relevant to the complex pathophysiology of ischemic stroke. The drug is associated with Shaanxi BuChang Pharmaceutical Co. LTD..
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nourishing Yin toning granule.